Literature DB >> 12207137

Pseudotumor cerebri in a patient with Goldenhar's and Duane's syndromes.

Oliver Tillman1, Hedwig J Kaiser, Hanspeter E Killer.   

Abstract

A 4-year-old boy presented with Goldenhar's syndrome, Duane's syndrome and bilateral papilledema. Magnetic resonance imaging of the brain was unremarkable. On lumbar puncture, the cerebrospinal fluid (CSF) pressure measured 36 cm H(2)O. CSF examination was normal. The diagnosis of pseudotumor cerebri was made, and treatment with acetazolamide was started. As the papilledema did not resolve, steroids were added to the treatment. Lumbar puncture was repeated after 1 month, and pressure was found to be 30 cm H(2)O. Because medical treatment was not effective in lowering the CSF pressure, optic nerve sheath fenestration was performed. Papilledema resolved over the next 2 months. To the best of our knowledge, this is the first case of Goldenhar's syndrome associated with pseudotumor cerebri. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12207137     DOI: 10.1159/000063849

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  3 in total

Review 1.  Pseudotumor cerebri.

Authors:  Paul W Brazis
Journal:  Curr Neurol Neurosci Rep       Date:  2004-03       Impact factor: 5.081

2.  Duplication 8q12: confirmation of a novel recognizable phenotype with duane retraction syndrome and developmental delay.

Authors:  Cyril Amouroux; Marie Vincent; Patricia Blanchet; Jacques Puechberty; Anouck Schneider; Anne Marie Chaze; Manon Girard; Magali Tournaire; Christian Jorgensen; Denis Morin; Pierre Sarda; Geneviève Lefort; David Geneviève
Journal:  Eur J Hum Genet       Date:  2012-01-18       Impact factor: 4.246

3.  Coexistence of Idiopathic Intracranial Hypertension with Unilateral Duane Retraction Syndrome Type 1 in an Adult Female.

Authors:  Abdullah I Almater; Jawaher Jehad Alwatban; Arwa Z Alromaih; Motazz Alarfaj; Majed Al-Obailan
Journal:  Case Rep Ophthalmol       Date:  2022-04-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.